AI-based rehabilitation treatment combined with standard treatmentTreatment as Usual (TAU)
AI-based rehabilitation treatment combined with standard treatment: Participants were offered a 3-week psychological intervention , delivered by the AI-based rehabilitation system. The system contains 12 core topics, such as basic knowledge and emotion regulation, cognitive restructuring, behavior activation, interpersonal communication skills, mindfulness and sleep, and relaxation training. The intervention schedule was 4 sessions per week, each lasting approximately 20 minutes, for a total of 12 sessions.
Treatment as Usual (TAU): Both groups will receive treatment as usual, including medication, exercise and psychological education.
Study summary
The trail aimed to test the efficacy of AI-based rehabilitation treatment in patients with anxiety disorders. Specifically, the objective of this trial is to determine whether the AI-based rehabilitation combined with treatment as usual is more effective than treatment as usual alone in improving outcomes in patients with anxiety disorders.
Eligibility
Sex
ALL
Min age
18 Years
Max age
60 Years
Healthy volunteers
No
1\. Subjects with anxiety disorders
* Inclusion Criteria:
* In accordance with ICD-11 for Anxiety Disorders;
* Between the ages of 18-60;
* Completed at least 9 years of education;
* Ability to use computers or smartphone;
* Native Chinese speaker;
* Signing informed consent.
* Exclusion Criteria:
* With severe psychiatric symptoms requiring hospitalization, or unable to complete the required assessment and treatment;
* Use of cognitive-enhancing medications within the past 6 months;
* With intellectual, visual, or auditory impairments that affect their ability to interact with aided-diagnostic systems.
Primary outcome measure(s)
Change from baseline in anxiety symptoms, as measured by the Generalized Anxiety Disorder 7-item Scale (GAD-7) — Assessed at baseline (T0), immediately post-intervention at week 3 (T1), and follow-up at week 7 (T2). Change in anxiety symptoms, measured by reduction in total score and rate of score reduction on the Generalized Anxiety Disorder 7-item Scale (GAD-7). The GAD-7 total score ranges from 0 to 21, with higher scores indicating greater severity of anxiety symptoms.
Trial sites (1)
Facility
City
Region
Status
Shanghai Mental Health Center
Shanghai
Shanghai Municipality
More Shanghai Mental Health Center trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.